Active Shortage

MINT-ENTACAPONE

MINT PHARMACEUTICALS INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of MINT-ENTACAPONE in Canada?

Yes. MINT-ENTACAPONE 200MG has an active shortage reported to Health Canada (last updated October 27, 2026).

Why is MINT-ENTACAPONE not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will MINT-ENTACAPONE be available again?

The manufacturer's estimated resolution date is January 31, 2027. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusActive Shortage

Same-ingredient products on file2 products

Expected resolution~3 months remaining (estimate)

Affected strength200MG

Report last updated2026-10-27

Checked by MedShort2026-11-13

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

SANDOZ ENTACAPONE

SANDOZ CANADA INCORPORATED

200MG · DIN 02380005

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

TEVA-ENTACAPONE

TEVA CANADA LIMITED

200MG · DIN 02375559

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.

Estimated Resolution

2027-01-31

~3 months remaining (estimate)

This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02535939

Strength

200MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

ENTACAPONE

Tier

Unrated

Last Updated

2026-10-27

Reason for Shortage

Disruption of the manufacture of the drug.

Source

View original report on healthproductshortages.ca ↗

Other Products from MINT PHARMACEUTICALS INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

300MG · DIN 02480956

10MG · DIN 02468840

25MG · DIN 02468859

200MG · DIN 02524708

400MG · DIN 02524716

800MG · DIN 02524724